BLPH logo

Bellerophon Therapeutics (BLPH) Current Assets

Annual Current Assets

$7.56 M
-$17.90 M-70.29%

December 31, 2022


Summary


Performance

BLPH Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLPHbalance sheetmetrics:

Quarterly Current Assets

$4.98 M
-$6.27 M-55.72%

September 30, 2023


Summary


Performance

BLPH Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLPHbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

BLPH Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-70.3%-58.7%
3 y3 years-27.1%-58.7%
5 y5 years-78.7%-77.9%

BLPH Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-70.3%at low-80.4%at low
5 y5-year-84.3%at low-91.7%at low
alltimeall time-84.3%-95.8%-93.2%-68.8%

Bellerophon Therapeutics Current Assets History

DateAnnualQuarterly
Sep 2023
-
$4.98 M(-55.7%)
Jun 2023
-
$11.24 M(-28.7%)
Mar 2023
-
$15.77 M(+108.5%)
Dec 2022
$372.00 K(-73.7%)
$7.56 M(-37.3%)
Sep 2022
-
$12.06 M(-29.0%)
Jun 2022
-
$16.99 M(-17.2%)
Mar 2022
-
$20.52 M(-19.4%)
Dec 2021
$1.42 M(-34.4%)
$25.46 M(-14.3%)
Sep 2021
-
$29.71 M(-15.8%)
Jun 2021
-
$35.29 M(-12.3%)
Mar 2021
-
$40.22 M(-16.3%)
Dec 2020
$2.16 M(-20.8%)
$48.08 M(-12.1%)
Sep 2020
-
$54.71 M(-9.3%)
Jun 2020
-
$60.31 M(+566.7%)
Mar 2020
-
$9.05 M(-12.9%)
Dec 2019
$2.73 M(+182.8%)
$10.38 M(-24.0%)
Sep 2019
-
$13.65 M(-23.0%)
Jun 2019
-
$17.73 M(-18.4%)
Mar 2019
-
$21.73 M(+24.9%)
DateAnnualQuarterly
Dec 2018
$964.00 K(-21.6%)
$17.40 M(-22.8%)
Sep 2018
-
$22.54 M(-21.7%)
Jun 2018
-
$28.79 M(-17.2%)
Mar 2018
-
$34.76 M(-2.3%)
Dec 2017
$1.23 M(-61.5%)
$35.58 M(-9.7%)
Sep 2017
-
$39.40 M(+93.3%)
Jun 2017
-
$20.38 M(-12.3%)
Mar 2017
-
$23.24 M(-12.3%)
Dec 2016
$3.20 M(-64.3%)
$26.50 M(+51.2%)
Sep 2016
-
$17.52 M(-5.9%)
Jun 2016
-
$18.63 M(-19.3%)
Mar 2016
-
$23.09 M(-21.6%)
Dec 2015
$8.96 M(+56.9%)
$29.45 M(-37.1%)
Sep 2015
-
$46.86 M(-23.0%)
Jun 2015
-
$60.86 M(-17.3%)
Mar 2015
-
$73.57 M(+165.8%)
Dec 2014
$5.71 M(+174.0%)
$27.68 M(-33.2%)
Sep 2014
-
$41.44 M(+2570.1%)
Dec 2013
$2.08 M(-31.2%)
$1.55 M
Dec 2012
$3.03 M
-

FAQ

  • What is Bellerophon Therapeutics annual total current assets?
  • What is the all time high annual current assets for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics annual current assets year-on-year change?
  • What is Bellerophon Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Bellerophon Therapeutics?
  • What is Bellerophon Therapeutics quarterly current assets year-on-year change?

What is Bellerophon Therapeutics annual total current assets?

The current annual current assets of BLPH is $7.56 M

What is the all time high annual current assets for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high annual total current assets is $48.08 M

What is Bellerophon Therapeutics annual current assets year-on-year change?

Over the past year, BLPH annual total current assets has changed by -$17.90 M (-70.29%)

What is Bellerophon Therapeutics quarterly total current assets?

The current quarterly current assets of BLPH is $4.98 M

What is the all time high quarterly current assets for Bellerophon Therapeutics?

Bellerophon Therapeutics all-time high quarterly total current assets is $73.57 M

What is Bellerophon Therapeutics quarterly current assets year-on-year change?

Over the past year, BLPH quarterly total current assets has changed by -$7.08 M (-58.71%)